United States · FDA National Drug Code directory
ZIIHERA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68727-950_526942b1-adcb-4202-82ab-3d5eaaefc812
- Product NDC
- 68727-950
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- zanidatamab-hrii
- Labeler
- Jazz Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20241120
- Source listing expiry
- 20271231
Source-listed ingredients
- ZANIDATAMAB — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 VIAL, SINGLE-DOSE in 1 CARTON (68727-950-02) / 6 mL in 1 VIAL, SINGLE-DOSE (68727-950-01) · 68727-950-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →